Bromday Approval History
FDA Approved: Yes (Discontinued) (First approved October 16, 2010)
Brand name: Bromday
Generic name: bromfenac
Dosage form: Ophthalmic Solution
Previous Name: XiDay
Company: Bausch & Lomb Inc.
Treatment for: Postoperative Ocular Inflammation
Marketing Status: Discontinued
Bromday (bromfenac ophthalmic solution) is a once-daily ocular nonsteroidal anti-inflammatory agent for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Development History and FDA Approval Process for Bromday
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.